Review of the standard may limit imports via RDC 660 if there is a national equivalent; director Thiago Campos presents his point of view

The National Narcotics Fund (FNE) will no longer require Export Certificates for shipments destined to patients (Individuals) in Brazil, eliminating a bureaucratic obstacle that hindered the flow of derivatives between the two countries

Resumption of review by Anvisa and final deadline from STJ for cultivation define the sector's direction in the first quarter of the year

Adesaf Institute points out unconstitutionality in vetoing workers with a criminal history in research areas and requests a review of the measure

National mobilization seeks to maintain Anvisa's RDC 660/2022 and avoid risks to the continuity of treatments for thousands of patients

Companies report delays in shipments clearance, while official data from Anvisa indicate reduced average deadlines and a high approval rate

Partnership with TWA Brands foresees early purchase of products registered with Anvisa and marks the entry of the European company into Brazil

Marcelo Mario Matos Moreira assumes as substitute in the Fourth Board, filling the vacancy of the former rapporteur of the review of RDC 327

Letter brings together experts from across the country and includes UFLA participation

New regulation simplifies registration and expands the use of biodiversity in herbal medicines, as soon as cannabis products are classified as medicines, they must comply with these standards.

Rômison Rodrigues Mota leaves the position after a request for review delays the norm's vote; the topic will return to the regulatory agenda for 2026-2027

A group of 58 specialists from public and private universities advocates for evidence-based regulations for the cultivation and regulation of cannabis in Brazil

Document sets regulatory priorities, including rules for cannabis cultivation, updates to resolutions, and adjustments to the sector's health framework

Approved document defines 161 priority topics for the next two years, including national cultivation of low-THC cannabis

According to Marcelo Polacow Bisson, excluding pharmacies' manipulation leads to lack of assistance; Anvisa's proposed text on the Cannabis regulation is also criticized for bypassing procedural rites

The regulatory agency published the decision in the Official Gazette of the Union this Monday (8), allowing the inclusion of the dosage of 300 mg/ml

Proposal in the review of RDC 327/2019 to RDC 660/2022 divides opinions and raises doubts about access and judicialization

The Brazilian Association of Pharmaceutical Inputs Industry trusts that the request for a view by director Thiago Campos will result in a more in-depth analysis, maintaining the expectation of concluding the regulatory framework in January 2026

The submission of scientific evidence is essential to support the regulation of cannabis cultivation in Brazil and complies with STJ's determination

The historic investment from the Financier of Studies and Projects (Finep) will finance cutting-edge structures in two regions of the country. The approval, combined with recent authorizations from Anvisa, boosts the development of the scientific bases of the "CBD Brazil" project with the central goal of reducing the costs of medicinal products in Brazil, subsidizing the national production chain